PEG-hemoglobin data

The Piscataway, N.J., company was to present data today showing that its PEG-hemoglobin blood substitute can enhance the tumor-killing effect of radiation, and was to give further animal evidence of its safety and efficacy in transfusions.

At the Congress of the International Society for Artificial Cells, Blood Substitutes, and Immobilization Biotechnology in Boston, the company was to report that rats injected with tumor cells and then treated with the blood substitute achieved two- to four-fold increases in tissue oxygen in the 2-3 cm tumors. ...